Patents Assigned to AnorMED, Inc.
  • Patent number: 5900430
    Abstract: Invented are methods of inhibiting the production of cytokines, particularly inhibiting the production of interleukin-1 and inhibiting the production of tumor necrosis factor in a mammal in need thereof which comprises administering to such mammal an effective amount of an azaspirane derivative.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: May 4, 1999
    Assignee: AnorMED, Inc.
    Inventors: Alison Mary Badger, Wanda Bernadette High
  • Patent number: 5817807
    Abstract: Macrocyclic compounds having 1, 4, 8, 11-tetraazacyclotetradecanyl group, show good selectivity against HIV-1 and HIV-2, in in vitro tests are disclosed.
    Type: Grant
    Filed: June 6, 1996
    Date of Patent: October 6, 1998
    Assignee: Anormed Inc.
    Inventors: Gary J. Bridger, Sreenivasan Padmanabhan, Renato T. Skerlj, Pedro E. Hernandez-Abad, Milind P. Sant